Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05790772 · ClinicalTrials.gov registry record · NA
Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers
A NA study of Hormone Disturbance and Endorphin Changes, sponsored by Touro University Nevada.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05790772: Completed NA study of Hormone Disturbance and Endorphin Changes, sponsored by Touro University Nevada.
NCT05790772 is a NA study of Hormone Disturbance and Endorphin Changes that has completed, run by Touro University Nevada. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05790772, a NA study of Hormone Disturbance and Endorphin Changes, has completed, sponsored by Touro University Nevada.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will recruit 20 male and female athletes of endurance training background. They will participate in 50 minutes of vigorous activity on a treadmill with 3 blood draws (before exercising, 50 minutes into exercising, and 30 minutes after completion of exercising). After collection of the blood samples, the results will be analyzed for extracellular vesicles and biochemical changes within said extracellular vesicles.
Primary Outcome
Endorphin expression (AU arbitrary unit) in Extracellular Vesicles within Blood Plasma via Western Blot
Conditions Studied
Interventions
- BEHAVIORAL Vigorous Exercise
Study Locations (1)
Nevada
- Touro University Nevada - Henderson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2023-07-23 |
| Phase | NA |
What the finished NCT05790772 record still lists
NCT05790772 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Hormone Disturbance appearing as the primary indexed condition, and to 1 intervention - of which Vigorous Exercise is the first listed.
NCT05790772 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT05790772 about?
NCT05790772 is a clinical study titled "Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers". This study will recruit 20 male and female athletes of endurance training background. They will participate in 50 minutes of vigorous activity on a treadmill with 3 blood draws (before exercising, 50 minutes into exercising, and 30 minutes after completion of exercising). After collection of the blo...
What is the current status of trial NCT05790772?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-03-01. Estimated completion is 2023-07-23.
What conditions does trial NCT05790772 study?
This clinical trial studies the following conditions: Hormone Disturbance, Endorphin Changes.
What interventions are being tested in trial NCT05790772?
The interventions under investigation include: Vigorous Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05790772?
This trial is sponsored by Touro University Nevada, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05790772 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hormone Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05790772's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI